Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
ZTS Zoetis Inc
HMPT Home Point Capital Inc
KWR Quaker Chemical Corp
TWO Two Harbors Investment Corp
BV Brightview Holdings Inc
PBPB Potbelly Corp
RLJ RLJ Lodging Trust
LHCG LHC Group Inc
KW Kennedy-Wilson Holdings Inc
Go

Health Care : Biotechnology | Large Cap Value
Company profile

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture and sale of a range of pharmaceutical products. Its products are focused on treating conditions, such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease and multiple sclerosis; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis, and other serious health conditions. It offers products in various categories, including HUMIRA (adalimumab), Oncology products, Virology Products, Additional Virology products, Metabolics/Hormones products, Endocrinology products and other products, which include Duopa and Duodopa (carbidopa and levodopa), Anesthesia products and ZINBRYTA (daclizumab).

Closing Price
$116.08
Day's Change
0.30 (0.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
116.18
Day's Low
114.16
Volume
(Average)
Volume:
5,803,752

10-day average volume:
6,301,980
5,803,752

Display:

Providers:

UpdateCancel
6 providers
May 03, 2021
Psoriasis Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Psoriasis Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06067846/?utm_source=GNW 86 billion in 2021 at a compound annual growth rate (CAGR) of...(Globe Newswire)

April 30, 2021
Thinking about trading options or stock in BioNTech, Alexion Pharmaceuticals, Pfizer, Exxon Mobil, or AbbVie?

InvestorsObserver issues critical PriceWatch Alerts for BNTX, ALXN, PFE, XOM, and ABBV. https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg Click a link below then choose between in-depth options trade idea report or a stock score...(PR Newswire)

April 23, 2021
HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030

Reportlinker.com announces the release of the report "HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030" - https://www.reportlinker.com/p06065174/?utm_source=GNW H. Boehringer Sohn AG & Ko. KG), AbbVie, Inc...(Globe Newswire)

April 08, 2021
Pharma Companies Seeking to Improve Health Outcomes With Innovative Products

Conditions such as HIV, asthma, hepatitis, and severe migraines affect the quality of life of those living with these conditions. These conditions require patients to take preventive or control medication to avoid adverse developments due to the...(PR Newswire)

April 07, 2021
AbbVie to Present Data Across its Robust Neuroscience Portfolio at the 2021 American Academy of Neurology (AAN) Annual Meeting

AbbVie (NYSE: ABBV) today announced new data from its expansive neuroscience portfolio will be presented at the 2021 American Academy of Neurology (AAN) Annual Meeting, to be held virtually from April 17-22. A total of 33 abstracts, including one...(PR Newswire)

April 02, 2021
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Moderate to Severe Atopic Dermatitis

AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the...(PR Newswire)

April 01, 2021
Global Uveitis Drugs Market- AbbVie Inc., Alimera Sciences Inc., Amgen Inc., among others to contribute to the market growth|Industry Analysis, Market Trends, Market Growth, Opportunities and Forecast 2025

https://mma.prnewswire.com/media/1477539/TECHNAVIO_DRUGS.jpg The uveitis drugs market is poised to grow by $ 248.42 mn during 2021-2025, progressing at a CAGR of almost 6% during the forecast period. (PR Newswire)

Selective Serotonin Reuptake Inhibitors (SSRIs) Market- AbbVie Inc., Apotex Inc., Aurobindo Pharma Ltd., among others to contribute to the market growth|Industry Analysis, Market Trends, Opportunities and Forecast 2025

https://mma.prnewswire.com/media/1477535/Technavio___SSRIs_market.jpg The selective serotonin reuptake inhibitors (SSRIs) market is poised to grow by $ 809.73 mn during 2021-2025, progressing at a CAGR of about 4% during the forecast period. (PR Newswire)

New England Journal of Medicine Publishes 24-Week Results from Phase 3 Study Evaluating RINVOQ(TM) (upadacitinib) in Psoriatic Arthritis

AbbVie (NYSE: ABBV) today announced that the New England Journal of Medicine has published 24-week results from the Phase 3 SELECT-PsA 1 trial evaluating RINVOQ(TM) (upadacitinib, 15 mg and 30 mg) in adults with active psoriatic arthritis who had...(PR Newswire)

March 31, 2021
AbbVie to Host First-Quarter 2021 Earnings Conference Call

AbbVie (NYSE: ABBV) will announce its first-quarter 2021 financial results on Friday, April 30, 2021, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through...(PR Newswire)

March 30, 2021
U.S. FDA Accepts AbbVie's New Drug Application for Atogepant for the Preventive Treatment of Migraine

AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for atogepant, an investigational orally administered calcitonin gene-related peptide (CGRP) receptor antagonist...(PR Newswire)

March 24, 2021
Controlling Inflammation to Stop Disease

In a natural response to injury or infection, the body produces chemicals that trigger the immune system to release antibodies and proteins plus increase blood flow to the afflicted area, which aids healing and produces inflammation. However, the...(PR Newswire)

Transplantation Market to Hit USD 14.67 Billion and Grow at 10.6% CAGR by 2028; Rising Prevalence of Chronic Diseases to Fuel Demand for Organ Transplantation: states Fortune Business Insights(TM)

The global transplantation market size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The rising prevalence of chronic diseases coupled with technological advancements will spur business...(Globe Newswire)

March 21, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV

New York, New York--(Newsfile Corp. - March 21, 2021) - Pomerantz LLP is investigating claims on behalf of investors of AbbVie Inc.("AbbVie" or the "Company") (NYSE: ABBV). Such investors are advised to contact Robert S. Willoughby at...(Newsfile)

March 18, 2021
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV

Pomerantz LLP is investigating claims on behalf of investors of AbbVie Inc.("AbbVie" or the "Company") (NYSE: ABBV). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. (PR Newswire)

March 17, 2021
AbbVie Announces Extension of Review for Supplemental New Drug Application of Upadacitinib for the Treatment of Adults with Active Psoriatic Arthritis

AbbVie (NYSE:ABBV), a global research and development-based biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the...(PR Newswire)

March 11, 2021
Global Parkinson's Disease Drugs Outlook to 2027, Featuring AbbVie Inc., Impax Laboratories Inc., Mylan NV, Orion Pharma and Pfizer Inc.

The "Parkinson's Disease Drugs - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Parkinson's Disease Drugs estimated at US$ 5.1 Billion in the...(Globe Newswire)

March 10, 2021
Active Pharmaceutical Ingredient Market to Hit USD 261.28 Billion and Exhibit 6.1% CAGR by 2026; Rising Demand for Biosimilar & Biologics to Drive Growth: Fortune Business Insights(TM)

The global Active Pharmaceutical Ingredient Market size is set to gain impetus from the rising implementation of strict norms and regulations in several countries regarding the production of high-quality API. It is further aiding in upsurging the...(Globe Newswire)

February 25, 2021
Allergan, an AbbVie Company, Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia

Allergan, an AbbVie (NYSE: ABBV) company, today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for investigational AGN-190584 (pilocarpine 1.25%) ophthalmic solution for the treatment of presbyopia...(PR Newswire)

February 24, 2021
Psoriasis Treatment Market Size Anticipated to Hit USD 37,634.2 Million with 9.2% CAGR by 2026; Rising Prevalence of Psoriasis Worldwide will Promote Growth | Fortune Business Insights(TM)

The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the...(Globe Newswire)

Next >

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.